. Author manuscript; available in PMC: 2009 Jul 1.

Published in final edited form as: Int Immunopharmacol. 2008 Apr 3;8(7):1012–1022. doi: 10.1016/j.intimp.2008.03.005

Table 1.

Potency of Adjuvant Formulations in Inducing Anti-MSP1-19 Antibodies in IFN-γ KO, IL-4 KO and STAT6 KO Mice as compared to Wild Type Controls ^@

	ISA720/ MPL	MPL-SE	MPL-AF	ISA720/QS21/MPL	ISA720	ISA720/QS21	QS21	MF59	CFA/IFA
IFN-γ KO	^o	^o	^o	^o	⁻	^o	⁺	^o	⁻
IL-4 KO	⁺	⁺	^o	⁺	^o	^o	^o	⁻	⁻
STAT6 KO	⁺	⁺	⁺	^o	⁻	^o	^o	⁻	⁻

^{@: +}

significant increase in antibody levels as compared to WT mice

⁻

significant decrease in antibody levels as compared to WT mice

no significant change in antibody levels as compared to WT mice